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Background {#Sec2}
==========

The liver fluke, *Opisthorchis viverrini* is a food-borne trematode endemic to Thailand, Lao PDR, Cambodia, Myanmar and Vietnam. It is known to be a significant public health burden in Lao PDR and Thailand \[[@CR1], [@CR2]\]. The most serious consequence of this infection is its association with the development of cholangiocarcinoma (CCA). *Opisthorchis viverrini* has been classified as a Group I biological carcinogen by the World Health Organization's International Agency on Research in Cancer \[[@CR3]\]. Globally the highest prevalence rates of *O. viverrini* infection, and the highest incidence rates of CCA, are found in Thailand, particularly in the northeast \[[@CR4]--[@CR7]\], where *O. viverrini* infection prevalence was estimated at 17% in 2009 \[[@CR2]\]. A later study in 2014 reported a prevalence of 23%, with infection being more common in men and people aged 40--49 years \[[@CR8]\]. *Opisthorchis viverrini* infection, and particularly repeated infection, is the primary risk factor for CCA in northeast Thailand \[[@CR6], [@CR9]--[@CR13]\].

The main source of infection with *O. viverrini* in Thailand is the consumption of uncooked or fermented cyprinid fish \[[@CR2], [@CR9], [@CR14], [@CR15]\]. This dietary behaviour is deeply embedded in the food culture of northeast Thailand, as well as the lower Mekong region generally \[[@CR16]\]. The main treatment for *O. viverrini* infection is praziqantel (PZQ), which is highly effective at eliminating the parasite. In Thailand, a single dose of 40 mg/kg PZQ has been used to treat opisthorchiasis since the mid-1980s \[[@CR17]\]. This effective treatment option may induce relaxed attitudes towards continued risky fish consumption behaviors, leading to re-infection \[[@CR18]\]. Around one-tenth of re-infections by *O. viverrini* is caused by this raw fish eating behavior \[[@CR19]\]. This continued consumption leads to individuals experiencing cycles of *O. viverrini* infection, treatment, and re-infection, a serious problem in highly endemic areas. This cycle increases the risk of progression to the development of CCA \[[@CR4]--[@CR7]\].

Previous studies have found that repeated treatment with PZQ, and therefore repeated infection with *O. viverrini*, is also associated with an increased risk of CCA developing \[[@CR13]\]. However, the intermediary step of measuring the association between the frequency of PZQ treatment and *O. viverrini* infection is less well understood. Assessing the magnitude of this association and identifying the most at risk groups for *O. viverrini* infection is a necessary step in designing policy responses that may help break the cycle of infection, treatment and re-infection. Studies of the association between previous treatment with PZQ and current *O. viverrini* infection have been carried out with small sample sizes and in specific parts of northeast Thailand \[[@CR18], [@CR20]\]. This study investigates this association using data from the largest screening program for *O. viverrini* and CCA in Thailand.

Methods {#Sec3}
=======

Study design {#Sec4}
------------

This study was carried out in the *O. viverrini* endemic area of northeast Thailand. Data pertaining to epidemiology, morbidity and treatment were obtained from study participants enrolled in the Cholangiocarcinoma Screening and Care Program (CASCAP) through the mobile screening team. CASCAP is the first project for CCA screening in a high-risk population with a community-based bottom-up approach \[[@CR21]\]. The CASCAP screening program aims to recruit all residents of northeast Thailand aged over 40 years and to conduct regular screening for CCA and its risk factors. Recruitment is achieved using multiple methods and settings including tertiary care hospitals, district level hospitals and through mobile screening sessions at the sub-district level. For this study we only included those participants who attended our mobile screening program. These mobile screening sessions used ultrasound (US) to detect the presence of hepatobiliary abnormalities such as periductal fibrosis, liver mass and bile duct dilatation. Screening also identified *O. viverrini* infection. Therefore, this study includes all individuals who participated in mobile screening for *O. viverrini* infection and CCA who were enrolled in the CASCAP database between June 2016 and July 2017. In addition to screening, participants also filled out a questionnaire containing socio-demographic information, history of using PZQ, and other health and lifestyle information.

Study setting and population {#Sec5}
----------------------------

Northeast Thailand (or Isan) is Thailand's largest region comprising 20 provinces located on the Khorat Plateau and bordered by the Mekong River and Laos to the north and east and Cambodia to the south. Northeast Thailand is located between latitudes 14.50°N and 17.50°N, and between longitudes 102.12°E and 104.90°E and covers an area of 168 854 km^2^. The population of northeast Thailand comprises approximately 21 million people, or around one third of the total Thai population. This is Thailand's poorest region and agriculture is the largest economic sector \[[@CR22]\].

Our study population was recruited as part of the CASCAP project based at Khon Kaen University. This project enlists participants and screens them for CCA risk factors and liver pathology, as well as providing treatment for the disease. Detailed recruitment procedures have been published elsewhere \[[@CR21]\]. One recruitment arm is through mobile screening clinics. In this arm research assistants from local sub-district level hospitals collaborate with civil registrars to obtain contact details for local residents. A random sample of the sub-district population, who were aged more than 40 years, were contacted and invited to participate in the mobile screening process. They then agreed to visit the local hospital for screening on the appointed day. As well as these actively recruited participants, patients attending the local hospital for other reasons are also invited to participate in screening. For this study a total of 3081 participants were recruited from seven provinces in northeast Thailand (Nong Khai, Sakon Nakhon, Bueng Kan, Udon Thani, Chaiyaphum, Khon Kaen, and Kalasin), all of which are *O. viverrini* endemic areas (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1Study area, including the 7 provinces Nong Khai (NK), Sakon Nakhon (SK), Bueng Kan (BK), Udon Thani (UD), Chaiyaphum (CP), Khon Kaen (KK), and Kalasin (KS)

Data collection procedures {#Sec6}
--------------------------

Upon attending the mobile screening clinic, participants were asked to sign a consent form after which a research assistant from the local hospital administered a questionnaire by face-to-face interview. This questionnaire collected socio-demographic information, history of previous praziquantel treatment, and other health and lifestyle information. Next, the participants were provided with a collection container and asked to supply a single specimen of urine. These specimens were then kept refrigerated before being sent to the laboratory at the Department of Parasitology at Khon Kaen University. Diagnostic testing for *O. viverrini* infection was carried out within 24 h of the sample being provided.

Polyline shapefiles for water sources and polygon shapefiles for sub-district level were obtained from the DIVA-GIS website (<http://www.diva-gis.org>). The distance from sub-district to water sources was determined using the proximity function in ArcGIS 10.5.1 (ESRI Inc., Redlands, CA, USA).

Diagnostic procedures {#Sec7}
---------------------

Opisthorchiasis diagnosis is commonly based on the detection of parasite eggs under a light microscope after faecal concentration using the formalin ethyl-acetate concentration technique (FECT). This method has limited diagnostic sensitivity and specificity for light *O. viverrini* infections and requires a specialist parasitologist to confirm *O. viverrini* eggs in the faeces as these are frequently confused with the eggs of minute intestinal flukes (MIFs). At present, a new method for the diagnosis of opisthorchiasis is a monoclonal antibody-based enzyme-linked immunosorbent assay for measuring the *O. viverrini* excretory-secretory (ES) antigens in urine (urine OV-ES assay) \[[@CR23]\]. When compared with the gold standard FECT method, this assay has a sensitivity and specificity of 81 and 70%, respectively. This agreement, combined with the non-invasive nature of the collection (through urine) and its ease of use, make it an ideal method for use in mobile screening \[[@CR23]\]. In this study, the data on *O. viverrini* infection was based on antigen detection in urine.

Statistical analysis {#Sec8}
--------------------

Individuals were categorized as with or without *O. viverrini* infection. The factor of interest was history of using PZQ. This was categorized into four groups (never, 1 time, 2 times, 3 times, and more than 3 times). Other factors measured included gender, age, education level, main occupation, smoking history, alcohol consumption history, history of eating uncooked or fermented freshwater fish with scales, and distance from sub-district to water source, which has been associated with the likelihood of *O. viverrini* infection in other studies \[[@CR24], [@CR25]\].

Categorical variables were summarized using frequencies and percentages (i.e. number of previous PZQ treatments, gender, age groups, education levels, main occupation, smoking history, alcohol consumption history, history of raw fish eating, and distance from sub-district to water source). Continuous variables, such as age of participants in years and distance from sub-district to water source in kilometers, were summarized by their mean, standard deviation (SD), median, and range.

The prevalence of *O. viverrini* infection was computed as percentages, based on a normal approximation to a binomial distribution. Logistic regression analysis was performed to investigate the association between *O. viverrini* infection and underlying risk factors. Associations between repeated PZQ treatments and *O. viverrini* infection were determined by crude odds ratios (c*OR*) using simple logistic regression. Stratified analysis was used to investigate the effect of each factor on the association between other factors using a Mantel-Haenszel test. A multivariable analysis was then used to investigate the association between the frequency of previous PZQ treatments and current *O. viverrini* infection adjusted for the factors indicated. Adjusted odds ratios (*aOR*) and 95% confidence intervals (*CI*) were calculated using multiple logistic regression.

All test statistics were two-tailed and a *P*-value of less than 0.05 was considered statistically significant. All analyses were performed using the statistical package, STATA version 15 (Stata, College Station, Texas, USA).

Results {#Sec9}
=======

Descriptive summary {#Sec10}
-------------------

A total of 3081 participants who submitted urine samples for *O. viverrini* infection assessment were enrolled in the study (Table [1](#Tab1){ref-type="table"}). Participants were aged between 23 and 87 years, with a mean age of 54.1 (*SD* = 8.8) years. More than half of them were men (61.9%) and the majority had only completed primary school or had not completed any formal education (64%). Farming was the most common occupation (76.2%). Among study participants, 27.7% (855) had previously received PZQ treatment once, 8.2% (252) twice, 2.8% (85) three times, and 3.5% (107) more than three times. Figure [2](#Fig2){ref-type="fig"} shows the gender distribution of each PZQ treatment frequency group. Among those who had previously received PZQ treatment more than three times, 59.8% (64/107) were men.Table 1Demographic characteristics of participants presented as number and percentageCharacteristicsNumber (*n* = 3081)PercentageHistory of praziquantel treatment Never178257.8 Once85527.7 Twice2528.2 Three times852.8 More than three times1073.5Gender Women190861.9 Men117338.1Age groups (years) 40--4441713.6 45--4960419.6 50--5466921.8 55--5958218.9 60 years and over80226.1 Mean (standard deviation)54.06 (8.80)Education levels Primary and lower197264.0 Secondary88228.6 Certificate and higher2277.4Occupation Unemployed1143.7 Farmer234876.2 Others61920.1Smoking history No225773.3 Yes, current or previous82426.7Alcohol consumption history No112236.4 Yes, current or previous195963.6History of raw fish eating No1996.5 Yes, current or previous288293.5Distance from water source to sub-district \< 1 km288493.6 1 km and over1976.4 Mean (standard deviation)0.18 (0.65)Fig. 2Percentage of praziquantel treatments according to gender

Prevalence and association summary {#Sec11}
----------------------------------

Table [2](#Tab2){ref-type="table"} shows the associations between the frequency of previous PZQ treatment and current *O. viverrini* infection. From a total of 3081 participants, the overall prevalence of *O. viverrini* infection was 17%. The prevalence was 18.1% for those who used PZQ once, 19.8% twice, 21.2% three times, and 28% more than three times. Compared with participants who had never used PZQ, the *aOR* for *O. viverrini* infection among those who received the PZQ treatment once was 1.09 (95% *CI*: 0.88--1.37), two times was 1.19 (95% *CI*: 0.85--1.68), three times and more than three times was 1.28 (95% *CI*: 0.74--2.21) and 1.86 (95% *CI*: 1.18--2.93; *P* = 0.007), respectively. Figure [3](#Fig3){ref-type="fig"} shows the *aOR* for current *O. viverrini* infection by all demographic and health history factors. This figure reveals that positive, statistically significant relationships were found between increased age and frequent previous PZQ treatment and current infection, while living more than 1 km from a water source, and higher education were protective factors.Table 2Crude and adjusted odds ratio between history of praziquantel treatments and *O. viverrini* infection and 95% confidence interval adjusted for all other factors using multiple logistic regressionFactorsNumber% OV^a^*cORaOR*95% *CIP*-valueOver all308117.0NA^b^NA^b^NA^b^NA^b^History of PZQ treatment Never178215.211 Once85518.11.231.090.88--1.370.433 Twice25219.81.381.190.85--1.680.310 Three times8521.21.501.280.74--2.210.375 More than three times10728.02.17\*1.861.18--2.930.007Gender Women190815.711 Men117319.11.27\*1.070.79--1.440.667Age group (years) 40--4441710.311 45--4960414.11.421.320.89--1.960.168 50--5466916.61.73\*1.541.05--2.250.027 55--5958217.01.78\*1.591.08--2.360.019 60 years and over80223.22.63\*2.101.44--3.040.000Education levels Primary and lower197219.911 Secondary88213.30.62\*0.760.60--0.960.022 Certificate and higher2276.60.29\*0.480.27--0.860.013Occupation Unemployed11418.411 Farmer234819.01.041.160.70--1.910.572 Others6199.10.44\*0.650.36--1.150.140Smoking history No225715.811 Yes, current or previous82420.41.37\*1.150.84--1.580.375Alcohol consumption history No112216.611 Yes, current or previous195917.31.050.960.76--1.210.749History of raw fish eating No19915.611 Yes, current or previous288217.11.120.970.65--1.470.908Distance of sub-district to water source \< 1 km288417.511 1 km and over19710.20.53\*0.600.37--0.970.038c*OR* Crude odds ratio, a*OR* Adjusted odds ratio\*indicates c*OR*s with a significance level of *P* \< 0.05^a^OV: *Opisthorchis viverrini*^b^Not applicableFig. 3Forest plot of adjusted odd ratios for the associations between past praziqantel treatment and socio-demographic factors and current *O. viverrini* infection

Analysis stratified by education level showed an association between previous treatment with PZQ and current *O. viverrini* infection. Participants who had education levels lower than secondary school, and who used PZQ more than three times, were 1.71 times (95% *CI*: 1.03--2.85; *P* = 0.038) more likely to be currently infected with *O. viverrini* compared with those who used PZQ three times or less (Table [3](#Tab3){ref-type="table"}).Table 3Effect of education level on the association between PZQ and current *O. viverrini* infectionFactorsNumber% OV^a^*cORaOR* ^b^95% *CIP*-valuePZQ treatment and *O. viverrini* infection by education level Less than secondary school0.038  Used PZQ 3 times and lower189419.511  Used PZQ more than 3 times7829.51.731.711.03--2.85 Secondary school and higher0.092  Used PZQ 3 times and lower108011.611  Used PZQ more than 3 times2924.12.432.150.88--5.25*PZQ* Praziquantel treatments, c*OR* Crude odds ratio, a*OR* Adjusted odds ratio^a^OV: *Opisthorchis viverrini*^b^Odds ratios adjusted for all factors includes history of PZQ treatment, education levels, gender, age at enrolment, occupation, smoking history, alcohol consumption history, history of raw fish eating, and distance of sub-district to water source

Discussion {#Sec12}
==========

The results of this study demonstrate the importance of continued public health interventions to address the risk factors for CCA, one of the leading causes of death among adults in northeast Thailand. This is particularly important in relation to infection with the liver fluke *O. viverrini.* Although the prevalence of infection with this parasite has decreased in the region over the past three decades, in recent years there appears to be a slowing of this reduction or even some resurgence \[[@CR2], [@CR18]\]. The data presented here reveal one of the major potential challenges in reducing this health burden, the cycle of infection and re-infection and associated repeated doses of PQZ. The positive association shown here between the frequency of previous use of PZQ and current *O. viverrini* infection shows the potential for complacency and continued risk taking dietary behaviour which is connected with the infection. The Thai Ministry of Public Health has been attempting to modify this behaviour through public health education campaigns alerting the population to the risks of eating raw or insufficiently fermented fish. The campaigns include disseminating knowledge about the liver fluke in the elementary school curriculum. However, the effect on raw fish eating behaviour is unclear.

In our analysis, the only factors that were significantly associated with current *O. viverrini* infection were frequency of previous PZQ treatment, education, age and distance from a water source. The association between frequent PZQ treatment and re-infection has also been shown in other studies of the liver fluke \[[@CR18], [@CR20]\]. This pattern of infection and re-infection after treatment has also been found in Vietnam \[[@CR26]\]. Another study in Laos found no significant association between past PZQ treatment and infection \[[@CR27]\], however, this study only measured whether the medication had ever been taken, not the frequency of previous treatments. This, therefore, is not directly comparable with our study.

We also found that higher education is protective against both current *O. viverrini* infection and previous treatment with PZQ. This has also been observed in other studies \[[@CR28], [@CR29]\], carried out in other regions of northeast Thailand. Given that the primary health interventions carried out in northeast Thailand for *O. viverrini* infection comprise provision of PZQ treatment and public health campaigns regarding raw fish eating behaviour, it is possible that more educated individuals may be more receptive to these campaigns and more willing to change eating patterns. We do not have evidence of this in our data, however, more highly educated people may adopt other factors influencing dietary change and reduced raw fish consumption.

The pattern observed regarding associations between increasing age and infection risk may also be influenced by the traditional behaviour of eating raw/ fermented fish. The eating of traditional and culturally valued foods, which are risk factors for *O. viverrini* infection, may be harder to change in the older generations. However, it is noteworthy that other studies have found that infection rates increase across age groups but then reduce after age 50 years \[[@CR28]\], and another shows no association between age and infection \[[@CR18]\], although this study may have been underpowered. Other analyses have examined *O. viverrini* infection rates in different cohorts of children born over the last six decades revealing substantial falls in infection among school children over this time, corresponding to education programs that may now be having effect and possibly leading to reductions in CCA in the future \[[@CR30]\]. The final risk factor revealed in our study is proximity to water sources. This association has been found in other studies \[[@CR8], [@CR28], [@CR31]\], and is likely to be associated with fishing related occupations, or fishing for self-consumption, being more common amongst those living closer to water sources. The occupation data collected in this project, though, were not detailed enough to show any association with risk of *O. viverrini* infection.

A limitation of our study was that the data regarding the history of PZQ treatment was self-reported. The results may therefore involve potential recall bias with participants estimating their PZQ treatment frequency. Also, all participants reported a history of previous consumption of raw/fermented fish, but information on frequency, interval and amount of consumption was not assessed. This information may have given more explanatory power to the differences in *O. viverrini* infection observed between study participants. Also, this study was conducted in northeast Thailand and may not reflect the general population. Further study is necessary in the region to test the generality of our results. Nevertheless, the methodology and results of our study can be used as a guideline in formulating clinical practice and future research priorities.

Finally, other studies have shown that the urinary marker for *O. viverrini* infection can also indicate hepato-biliary diseases (HBD) such as periductal fibrosis, which may result from previous, treated, *O. viverrini* infections \[[@CR32]\]. There is therefore some risk that the participants we identify in this paper as having *O. viverrini* infection may in fact be experiencing HBD as a result of past infection. A further analysis of our data could not identify any association between being positive for *O. viverrini* infection and current HBD, which is also assessed by the mobile screening clinics (Additional file [2](#MOESM2){ref-type="media"}: Table S1). This indicates that our results identify *O. viverrini* infection and not other HBD.

There is also some risk that even after treatment the antigen may stay in the urine meaning we have not only identified current infections in our analysis. However, other studies have shown that after PZQ treatment in urine antigen positive cases, the antigen concentration is cleared or declines to a negative level starting from 4 weeks onward. The patient was antigen negative up to 6 months post treatment if there is no reinfection (Worasith et al., unpublished data). The urine antigen positive cases could be either *O. viverrini* fecal egg-positive or egg-negative \[[@CR23]\]. In contrast to antibody against *O. viverrini* antigen, antigen detection in urine can differentiate current infection from past infection. Urine antigen has also been confirmed by copro-antigen detection and comparable results were observed. The presence of antigen in urine is quite stable for at least 10 months in antigen positive cases that had no drug treatment.

Conclusions {#Sec13}
===========

In conclusion, our findings have identified population groups within northeast Thailand that have had frequent previous PZQ treatment, and that also have current *O. viverrini* infection. Our results reveal that the association of current *O. viverrini* infection increased with the number of PZQ used. These findings suggest that this group of participants are continuing raw fish consumption and experiencing cycles of infection, treatment and re-infection. This is a particular problem in highly endemic areas for *O. viverrini* and increases the risk of cholangiocarcinoma. The findings confirm the need for continued and strengthened public health campaigns regarding the risks of *O. viverrini* infection, and particularly the increased risk with repeated re-infection, and the need for dietary modification. All participants in the CASCAP study receive annual ultrasound screening for the hepatobiliary abnormalities associated with *O. viverrini* infection, which may indicate progression towards CCA.
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